EGFR and periodontal disorder: demonstrated that inhibiting EGFR signaling significantly reduced inflammatory bone loss in a periodontal disease (PD) model.[15] These findings underscore the role of EGFR in bone biology and its potential as a therapeutic target in inflammatory conditions.